(Q34318557)

1 August 2017

title

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients (English)

1 reference

1 August 2017

0 references

H J van Megen

1

1 reference

1 August 2017

H G Westenberg

2

1 reference

1 August 2017

J A den Boer

3

1 reference

1 August 2017

J R Haigh

4

1 reference

1 August 2017

M Traub

5

1 reference

1 August 2017

publication date

1 April 1994

1 reference

1 August 2017

1 reference

1 August 2017

volume

114

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

449-455

1 reference

Cholecystokinin-4 and panic.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02249335

Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02249335

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02249335

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02249335

Lactate provocation of panic attacks. II. Biochemical and physiological findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02249335

Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02249335

Plasma concentrations of melatonin in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02249335

The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02249335

Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02249335

Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat

21 January 2018

1 reference

12 December 2020

Cholecystokinin receptor subtypes and neuromodulation

1 reference

12 December 2020

CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens.

1 reference

12 December 2020

Two brain cholecystokinin receptors: implications for behavioral actions.

1 reference

12 December 2020

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

1 reference

12 December 2020

Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment

1 reference

12 December 2020

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

12 December 2020

Lactate infusions: the role of baseline anxiety.

1 reference

12 December 2020

Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain.

1 reference

12 December 2020

Neuronal cholecystokinin: one or multiple transmitters?

1 reference

12 December 2020

Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.

1 reference

12 December 2020

Cholecystokinin receptor binding in brain and pancreas: regulation of pancreatic binding by cyclic and acyclic guanine nucleotides

1 reference

12 December 2020

5-HT1A receptor-effector system responsivity in panic disorder

1 reference

12 December 2020

Serotonergic stimulation of pituitary-adrenocortical function in rats

1 reference

12 December 2020

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

1 reference

12 December 2020

Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder.

1 reference

12 December 2020

Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists

1 reference

12 December 2020

Systemically administered cholecystokinin affects an evoked potential in the hippocampal dentate gyrus

1 reference

12 December 2020

The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus

1 reference

12 December 2020

Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire.

1 reference

12 December 2020

Stress-induced synthesis of melatonin: Possible involvement of the endogenous monoamine oxidase inhibitor (tribulin)

1 reference

12 December 2020

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

12 December 2020

Behavioral biochemical and neuroendocrine concomitants of lactate-induced panic anxiety.

1 reference

12 December 2020

The determination of cortisol in human plasma: evaluation and comparison of seven assays

1 reference

12 December 2020

Cholecystokinin and cholecystokinin antagonists enhance postsynaptic excitability in the dentate gyrus

1 reference

12 December 2020

Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. III. Inactivation of CCK-8 by a phosphoramidon-sensitive endopeptidase

1 reference

12 December 2020

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02249335

1 reference

Dimensions Publication ID

1 August 2017

1046741271

0 references

1 reference